Joseph Barsuglia
Clinical Researcher in Psychedelic Medicine
Papers
Trials
Key Impact
Notable for conducting real-world and clinical case studies on 5‑MeO‑DMT and ibogaine, exploring their therapeutic potential for PTSD, mood disorders and substance use disorders.
Background & Research
Joseph P. Barsuglia is a clinical researcher working at the intersection of psychedelic medicine and addiction/psychiatric care. His recent contributions emphasise pragmatic, real‑world investigations—ranging from longitudinal case studies of 5‑MeO‑DMT for post‑traumatic stress disorder and suicidality to naturalistic group‑setting evaluations that report unintended improvements in anxiety and depression. Barsuglia has also contributed to case reports and SPECT imaging studies that examine sequential administration strategies combining ibogaine and 5‑MeO‑DMT for alcohol use disorder, and he has authored mixed‑method analyses of persisting effects following ibogaine detoxification.